RUSSIAN EXPERT SYSTEM ORISKON – ASSESSMENT OF THE MAJOR NON-COMMUNICABLE DISEASE RISK
https://doi.org/10.15829/1728-8800-2013-4-51-55
Abstract
A new medical technology ORISKON (assessment of the major noncommunicable disease risk) is the first Russian expert system (ES) which not only assesses absolute and relative total levels of 10-year individual risk of major chronic non-communicable diseases (NCD), but also identifies high-risk groups and provides the basis for targeted, effective and cost-effective preventive interventions in these groups. This ES was developed using the prospective data of the 20-year follow-up of large representative population samples. Health parameters and factors used for the risk assessment were selected and defined according to the principles of evidence-based medicine and the expert recommendations and standards by the World Health Organization. While this ES is not a diagnostic tool, it can be used for the assessment of total NCD risk on its own or as a cost-effective component of the complex examination during dispanserisation and preventive screening.
About the Authors
S. A. Shalnova
State Research Centre for Preventive Medicine, Moscow
Russian Federation
tel.: 8 (903) 238-87-83
Russian Federation
tel.: 8 (903) 238-87-83
A. M. Kalinina
State Research Centre for Preventive Medicine, Moscow
Russian Federation
Russian Federation
A. D. Deev
State Research Centre for Preventive Medicine, Moscow
Russian Federation
Russian Federation
A. V. Pustelenin
State Research Centre for Preventive Medicine, Moscow
Russian Federation
Russian Federation
References
1. Federal law dated November 21, 2011. № 323-FL “About health protection of the of citizens in the Russian Federation”. http://base.consultant.ru/cons/ cgi/online.cgi?req=doc; base=law; n=121895&utm_campaign=hotdocs_ day5572942&utm_source=ya.direct&utm_medium=cpc&utm_ content=55768005 Russian (Федеральный Закон от 21 ноября 2011 г. № 323-Ф3 “Об охране здоровья граждан в Российской Федерации”. http://base.consultant.ru/cons/cgi/online.cgi?req=doc; base=law; n=121895&utm_campaign=hotdocs_day5572942&utm_source=ya. direct&utm_medium=cpc&utm_content=55768005).
2. State program of the public health development in Russian Federation. http:// www.rosminzdrav.ru/health/72. Russian (Государственная программа развития здравоохранения Российской Федерации. http://www.rosminzdrav. ru/health/72).
3. World Bank (2005). Dying too young: addressing premature mortality and ill health due to noncommunicable diseases and injuries in the Russian Federation (2005). Washington, DC, World Bank.
4. Global status report on nocommunicable diseases 2010. WHO 2011. http:// whqlibdoc.who.int/publications/2011/9789240686458_eng.pdf.
5. Oganov RG, Maslennikova GYa. Mortality from cardiovascular and other noncommunicable diseases among the working population of Russia. Cardiovascular Therapy and Prevention 2002; 2 (3):4–8. Russian (Оганов Р. Г., Масленникова Г. Я. Смертность от сердечно-сосудистых и других неин- фекционных заболеваний среди трудоспособного населения России. Кардиоваскулярная терапия и профилактика 2002; 3:4–8).
6. WHO Regional Office for Europe. Course on the recovery. European strategy of noncommunicable diseases prevention. EUR/RC56/R22006:60. http// www/who/int/pubrequest Russian (ВОЗ Европейской Региональное бюро. Курс на выздоровление. Европейская стратегия профилактики и борьбы с неинфекционными заболеваниями. EUR/RC56/R22006:60).
7. Eichler K, Puhan MA, Steurer J, et al. Prediction of first coronary events with the Framingham score: A systematic review. Am Heart J 2007; 153:722–31.
8. Anderson KM, Wilson PW, Odell PM, Kannel WB. An updated coronary risk profile. A statement for health professionals. Circulation 1991; 83:356–62.
9. D’Agostino RB Sr, Grundy S, Sullivan LM, Wilson P, CHD Risk Prediction Group. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 2001; 286:180–7.
10. Menotti A, Puddu PE and Lanti M. Comparison of the Framingham risk function-based coronary chart with risk function from an Italian population study. Eur Heart J 2000; 21:365–70.
11. Marrugat J, D’Agostino R, Sullivan L, et al. An adaptation of the Framingham coronary heart disease risk function to European Mediterranean areas. J Epidemiol Comm Health 2003; 57:634–8.
12. Hense HW, Schulte H, Lowel H, Assmann G, Keil U. Framingham risk function overestimates risk of coronary heart disease in men and women from Germany – results from MONICA Augsburg and the PROCAM cohorts. Eur Heart J 2003; 3:1–9.
13. Thomsen TF, McGee D, Davidsen M, Jorgensen T. A cross-validation of riskscores for coronary heart disease mortality based on data from the Glostrup Population Studies and Framingham Heart Study. Int J Epidemiol 2002; 31:817–22.
14. Conroy RM, Pyorala K, Fitzgerald AP, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003; 24: 987–1003.
15. Ramsay SE, Morris RW, Whincup PH, et al. Prediction of coronary heart disease risk by Framingham and SCORE risk assessments varies by socioeconomic position: results from a study in British men. Eur J Cardiovasc Prev Rehabil 2011; 18 (2):186–93.
16. Global Programm on Evidence for Health Policy; WHO, World health Report, 2002.
17. Kalinina AM. Influence of the multifactor ischemic heart disease prevention on some health indicators and prediction of life (10-year follow-up). The author’s abstract of the Doct Diss. М 1993; 46 p. Russian (Калинина А. М. Влияние многофакторной профилактики ишемической болезни сердца на неко- торые показатели здоровья и прогноз жизни (10-летнее наблюдение). Автореф докт мед наук. М. 1993; 46 c).
18. European guidelines on cardiovascular disease prevention in clinical practice. Third joint Task Force of European and other societies on cardiovascular disease prevention in clinical practice. Eur Heart J 2003; 24:1601–19.
19. Shalnova S, Oganov RG, Deev AD. Cardiovascular risk assessment and management for the population of Russia. Cardiovascular Therapy and Prevention 2004; 3 (4): 4–11. Russian (Шальнова С. А., Оганов Р. Г., Деев А. Д. Оценка и управление риском сердечно-сосудистых заболеваний для населения России. Кардиоваскулярная терапия и профилактика 2004; 3 (4):4–11).
20. Oganov RG, Shalnova SA, Kalinina AM, et al. A new method for evaluation of individual cardiovascular risk for the total population of Russia. Kardiologia 2008; 48 (5): 87–91. Russian (Оганов Р. Г., Шальнова С. А., Калинина A. M. и др. Новый способ оценки индивидуального сердечно-сосудистого сум- марного риска для населения России. Кардиология 2008; 48 (5): 87–91).
21. Hense HW, Schulte H, Lowel H, et al. Framingham risk function overestimates risk of coronary heart disease in men and women from Germany – results from MONICA Augsburg and the PROCAM cohorts. Eur Heart J 2003; 3:1–9.
22. Rose GA, Blachburn H, Gillum RF, Prineas RJ. Cardiovascular Survey Methods. WHO Monograph series No. 56 Geneva 1982, рр.149–153, 178 p.
23. Order of the Ministry of health of the Russian Federation from December 3, 2012 № 1006н “On approval of the clinical examination of certain groups of the adult population”. http://base.garant.ru/70355634 Russian (Приказ Министерства РФ от 3 декабря 2012 г. № 1006н “Об утверждении порядка проведения диспансеризации определенных групп населения”. http:// base.garant.ru/70355634).
24. Order of the Ministry of health of the Russian Federation from December 6, 2012 № 1011н “On approval of the procedure of preventive medical examinations”. http://mzsrrf.consultant.ru/page.aspx?1029514. Russian (Приказ Министерства РФ от 6 декабря 2012 г. № 1011н “Об утверждении порядка проведения профилактических медицинских осмотров”. http:// mzsrrf.consultant.ru/page.aspx?1029514).
25. Methodological recommendations on organization and conduct of a medical examination and preventive medical examinations. http://profmed.rosminzdrav. ru/documents/view00011/default.asp. Russian (Методические рекоменда- ции по организации и проведению диспансеризации и профилактиче- ских медицинских осмотров. http://profmed.rosminzdrav.ru/documents/ view00011/default.asp).
26. Cox DR and Oakes D. Analysis of Survival Data, London: Chapman and Hall, 1984:175 р.
27. Сox DR. Regression Models and Life Tables (with Discussion). J Royal Statistical Society, Series B, 1972; 34:187–220.
Review
For citations:
Shalnova S.A., Kalinina A.M., Deev A.D., Pustelenin A.V. RUSSIAN EXPERT SYSTEM ORISKON – ASSESSMENT OF THE MAJOR NON-COMMUNICABLE DISEASE RISK. Cardiovascular Therapy and Prevention. 2013;12(4):51-55. (In Russ.) https://doi.org/10.15829/1728-8800-2013-4-51-55
Views:
7708
Email this article 
